
Pasteur Network
Global alliance of 32 Pasteur institutes across 25 countries partnering with CEPI on vaccine R&D.
Last refreshed: 13 September 2026 · Appears in 3 active topics
How does the Pasteur Network link to the H5N1 vaccine trial and the Hondius sequencing?
Timeline for Pasteur Network
Named as French partner institution in the biomedical alliance
UK Startups and Innovation: UK and France sign science pactMentioned in: CEPI rescues Moderna H5N1 vaccine trial
Pandemics and BiosecurityExpanded partnership with CEPI on 21 April for regional vaccine R&D capacity
Pandemics and Biosecurity: Moderna begins Phase 3 H5N1 mRNA trialBackground
The Pasteur Network is an alliance of 32 member institutes across 25 countries on five continents, combining local presence with global scientific connections to address infectious disease, biosecurity and public health challenges. On 20 April 2026 it signed a Memorandum of Understanding with the Coalition for Epidemic Preparedness Innovations (CEPI) to expand collaboration on epidemiology and data Science, laboratory research and vaccine testing, clinical trials capacity in disease-endemic regions, biosecurity, and manufacturing, including mRNA vaccine capability. The partnership builds on existing links with network members such as Senegal's Institut Pasteur de Dakar and Brazil's Bio-Manguinhos/Fiocruz, both part of CEPI's Vaccine Manufacturing Facility Network. Separately, on 29 May 2026 the Institut Pasteur in Paris was a founding partner, alongside Oxford, Universite Paris Cite and others, of the UK-France Strategic Biomedical and AI Health Alliance targeting women's health, infectious disease and pandemic preparedness.